MIRA Pharmaceuticals, Inc.

MIRA Healthcare Drug Manufacturers General

In the quarter to June 2026, EPS grew 66.7% and free cash flow fell 50.8%, each against the same quarter a year earlier.

0.63 0.03 −4.55%
Market cap
$27.7M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Cash and Short Term Investments
8.11 9.41 11.03 7.54

+8 more quarters

Total current assets
8.17 9.43 11.06 7.60
Long-term receivables
0.04 0.04 0.04 0.04
Total non-current assets
0.04 0.04 0.04 0.04
Total Assets
8.20 9.46 11.09 7.63
Accounts Payable
0.04 0.03 0.13 0.08
Accrued Expenses
— 0.08 0.24 —
Total current liabilities
0.04 0.11 0.70 0.08
Total non-current liabilities
— — — —
Total liabilities
0.04 0.11 0.70 0.08
Additional Paid In Capital
50.10 50.08 49.97 41.14
Common Stock (Net)
0.00 0.00 0.00 0.00
Retained Earnings
(41.94) (40.73) (39.58) (33.60)
Common Equity (Total)
8.16 9.35 10.39 7.55
Shareholders Equity (Total)
8.16 9.35 10.39 7.55
Shareholders Equity and Liabilities (Total)
8.20 9.46 11.09 7.63
Shares (Common)
42.02 42.02 41.94 39.51
Shareholders Equity (Tangible)
8.16 9.35 10.39 7.55
Net Debt
(8.11) (9.41) (11.03) (7.54)

Fold the line items

In millions of $ except per-share values · columns are period end dates